Pharmacologic activation of PHD2 sensitizes non-small cell lung cancer cells to osimertinib. - Kim JS; Abeysiriwardhana HNI; Kim DK; Yoon TH; Choi JH; Liang Z; Kim JW; Liu KH; Lim Y; Yu JS; Cho SK; Cho M (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026)